JN

Jagan Nath

Director Director DIN 09149213
DIN 09149213 First appointment Apr 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2021
Shareholding value Locked Premium profile

About Jagan Nath

Data last updated:

Jagan Nath has 5 years in corporate governance. Formerly with 1 company, such as Emy Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09149213
Primary Designation Director
First Appointment 16 Apr 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Emy Pharmaceutical Private Limited U51397HR2021PTC094538
Director16 Apr 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Emy Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jagan Nath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagan Nath

Jagan Nath has 5 years in corporate governance. Formerly with 1 company, such as Emy Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Jagan Nath is associated with 0 companies as a director.

Jagan Nath has expertise in General Business.

Jagan Nath has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available